Lynching incidents shouldn't be politicised or given communal colour: Naqvi

Agencies
June 29, 2019

Mumbai, Jun 29: Union minister Mukhtar Abbas Naqvi Saturday said incidents of lynching should not be given a communal colour or politicised.

He was speaking to reporters after inaugurating a renovated hall of the Haj House in Mumbai. "Lynching is a criminal subject. It should not be give a communal colour. It is highly condemnable and no one should politicise it," the Minority Affairs Minister said.

The comment comes in the backdrop of the alleged lynching of a 24-year-old man in Jharkhand last week. The victim, Tabrez Ansari, was allegedly tied to a pole and thrashed with sticks by a mob in Seraikela Kharsawan district of Jharkhand on suspicion of theft. The man was purportedly seen in a video being forced to chant "Jai Shri Ram" and "Jai Hanuman". He later succumbed to injuries.

Naqvi said the culture of harmony and tolerance of majority Hindu community has built and strengthened the foundation of India's democratic secularism. "India is the world's largest secular democratic country because after partition, Pakistan chose to become an Islamic nation, while the majority Hindu community in India chose the path of secularism," he said.

Despite the diversity in languages, faiths, food and style of living, India's culture has kept us united through a strong bond. Today, the minorities in India are moving forward on the path of development with religious and social freedom, the minister said.

"The strong inclusive culture, unity and harmony of India has defeated terrorism and other enemies of humanity. Terrorist groups such as Al Qaeda and Islamic State have not been successful in their evil designs due to the commitment to unity of our society," the BJP leader said.

The Muslim community in India knows very well that terrorism is the biggest enemy of the entire humanity and Islam, he said.

"We should remain cautious to ensure that no negative agenda is successful in disturbing the atmosphere of inclusive development and harmony. We have to make secularism and democracy our strength and not a weakness," Naqvi said.

The minister said it was for the first time since independence that a record 2 lakh Indian Muslims will go on Haj this year without any subsidy. "An honest and transparent system developed by the Modi government has ensured that even after removal of Haj subsidy, there is no unnecessary financial burden on the Haj pilgrims," he said.

"A record number of two lakh Indian Muslims will go on Haj this year in over 500 flights from 21 embarkation points across the country," Naqvi said.

The number of women Haj pilgrims going without 'mehram' (male companion) this year is double as compared to last year, the minister added.

Comments

abdallah
 - 
Sunday, 30 Jun 2019

Dear Frank, yu should know that this Naqvi is not a muslim but sanghi and being used under muslim by bjp to fool muslims and hindus.   According to this devil, mob lynching of muslim is not a issue and triple is the core issue of muslims.   According to this hate monger, killing of muslims should not be discussed and focused as they are non indians.   As per this bulshit guy, bjp is also not concerned about mob lynching of muslims whereas death of a cow will be discussed in parliament and special bill will be passed for the safety of holy cow.    that is the reason why our great great PM is not ready to bring a bill of curbing mob lynching and instead bjp will award the person who kills muslims.   

Well Wisher
 - 
Sunday, 30 Jun 2019

This guy is bullshit

Mr Frank
 - 
Saturday, 29 Jun 2019

So according to Naqvi if one killed by minority is terrorism, and if killed by saffrons is lovely killed.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
June 30,2020

Seventy-seven per cent children below five years of age in Jammu and Kashmir were not able to access basic healthcare services like immunisation during the lockdown imposed to curb the spread of COVID-19, CRY said on Monday citing a study.

The 'Rapid Online Perception Study about the Effects of COVID-19 on Children' was conducted during the first and second phases of the lockdown based on responses of parents and primary caregivers from all across the country, including Jammu and Kashmir, the NGO said in a statement.

It said a total of 387 respondents from Jammu and Kashmir participated in the study.

"Seventy-seven per cent children of age 0-5 years were not able to access basic healthcare services such as immunisation during lockdown - necessarily imposed to curb the spread of COVID-19 pandemic in Jammu and Kashmir," Child Rights and You (CRY) said.

It said as immunisation programmes witnessed a major setback during the lockdown across the country, the results of the survey across 23 states and Union Territories found nearly 50 per cent of parents with children below five years of age unable to access immunisation services.

"Worryingly, the figure was considerably high in Jammu and Kashmir with 77.14 per cent children below five years unable to get immunisation services," it added.

According to the study, in Jammu and Kashmir, nearly 35 per cent of the respondents said their children did not receive medical help during the lockdown, resulting in difficulties to cope with their children's illnesses and health hazards.

The study also talks about more systemic arrangements and logistical preparedness to ensure that children with no or compromised digital reach are not deprived from their Right to Education.

With online classes introduced as a substitute of schools during the lockdown, access to education for children remained a major issue of concern, as many of them, especially the ones from marginalised and financially poorer backgrounds found it difficult without smartphones and internet access.

The survey's findings revealed that nationally only 41 per cent households with children of school-going age could access online classes on a regular basis.

"Almost 90 per cent parents and primary caregivers reported that the lockdown has increased the screen time of their child to great or some extent. About half of the households recorded an increase of children's exposure to online activities during lockdown," it said.

The NGO said around 76 per cent parents agreed that they could keep a watch of their children's online activity to some extent.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 3,2020

The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of the Oxford University developed Covid-19 vaccine candidate in the country.

Government officials said that the approval for conducting phase 2 and 3 clinical trials by the SII was granted by DCGI Dr V G Somani late Sunday night after a thorough evaluation based on the recommendations of the Subject Expert Committee (SEC) on Covid-19.

"The firm has to submit safety data, evaluated by the Data Safety Monitoring Board (DSMB), to the CDSCO before proceeding to phase 3 clinical trials," a senior official said.

"As per the study design, each subject will be administered two doses four weeks apart (first dose on day one and second dose on day 29) following which the safety and immunogenicity will be assessed at predefined intervals," the official said.

As a rapid regulatory response, the expert panel at the Central Drugs Standard Control Organisation (CDSCO) on Friday, after a detailed deliberation and considering the data generated on the vaccine candidate in phase 1 and 2 of the Oxford University trial, had recommended granting permission for phase 2 and 3 clinical trials of the potential vaccine, 'Covishield', on healthy adults in India,  the officials said.

Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa.

The officials said that the SII had submitted a revised proposal on Wednesday after the SEC on July 28, following deliberation over its application, had asked it to revise its protocol for the phase 2 and 3 clinical trials besides seeking some additional information.

The panel had also recommended that the clinical trial sites which have been proposed for the study be distributed across India.

According to the revised proposal by the SII, 1,600 people aged above 18 years will participate in the trials across 17 selected sites, including AIIMS-Delhi, B J Medical College in Pune, Rajendra Memorial Research Institute of Medical Sciences (RMRIMS) in Patna, Post Graduate Institute of Medical Education and Research in Chandigarh, AIIMS-Jodhpur, Nehru Hospital in Gorakhpur, Andhra Medical College in Visakhapatnam and JSS Academy of Higher Education and Research in Mysore.

"According to the application, it would conduct an observer-blind, randomised controlled study to determine the safety and immunogenicity of 'Covishield' on healthy Indian adults," the official said.

The SII, which has partnered with AstraZeneca, for manufacturing the Oxford vaccine candidate for Covid-19 had submitted its first application to the DCGI on July 25 seeking permission for conducting the phase 2 and 3 trials of the potential vaccine. 

Initial results of the first two-phases of trials of the vaccine conducted in five trial sites in the UK showed that it has an acceptable safety profile and homologous boosting increased antibody response, sources had said.

To introduce the vaccine, SII, the world's largest vaccine maker by number of doses produced and sold, has signed an agreement to manufacture the potential vaccine developed by the Jenner Institute (Oxford University) in collaboration with British-Swedish pharma company AstraZeneca. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 13,2020

New Delhi, May 13: With an increase of 3,525 COVID-19 cases reported in the last 24 hours, India's tally of positive coronavirus cases rises to 74,281 cases, as of Wednesday, said the Ministry of Health and Family Welfare.

The tally is inclusive of 47,480 patients who are active coronavirus cases and 24,385 patients who have been cured/discharged and one patient migrated.

With an increase of 122 deaths due to COVID-19 reported in the last 24 hours, the number of deaths in the country now stands at 2,415.

According to the ministry, Maharashtra has the most number of positive COVID-19 cases with 24,427 positive cases that include 5,125 patients recovered and 921 fatalities.

Gujarat has reported 8,903 COVID-19 cases inclusive of 3,246 recovered patients and 537 deaths due to the coronavirus.

Tamil Nadu reported 8,718 positive coronavirus cases with 2,134 patients recovering from the disease and 61 succumbing to the infection.

Delhi's tally of COVID-19 cases stands at 7,639 cases with 2,512 patients recovering and 86 patients died due to coronavirus.

Meanwhile Arunachal Pradesh (one case reported--now recovered), Goa (seven cases reported--all seven recovered), Manipur (two cases reported--both recovered) and Mizoram (one case reported--now recovered) have reported no new cases of COVID-19.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.